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E-mail address: xinlew@amgen.com (X. Wu).Adhesion G-protein-coupled receptors (GPCR) are special members of GPCRs with long N-termini
containing multiple domains. We overexpressed our collection of receptors together with G-pro-
teins in mammalian cell lines and measured the concentrations of intracellular signaling molecules,
such as inositol phosphate and cAMP. Our results show that a subset of tested adhesion GPCRs has
constitutive activities and is capable of coupling to a variety of G-proteins. In addition, we have iden-
tiﬁed a small molecule compound that speciﬁcally activates one of the subfamily members, GPR97,
and the activation was conﬁrmed by an independent GTPcS assay. These ﬁndings suggest classical
GPCR screening assays could be applied to de-orphanize these receptors, and provide pharmacolog-
ical tools to improve understanding of the physiological functions of these receptors.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The superfamily of G-protein-coupled receptors (GPCRs) is one
of the largest and most studied families of proteins in the mamma-
lian genome. The ligands for this superfamily are extremely di-
verse. GPCRs have been very successful pharmaceutical targets,
with around 50% of all newly introduced drugs targeted against
this superfamily [1]. There are over 800 GPCRs in the human gen-
ome, and they form ﬁve major subfamilies [1]. One rather new and
peculiar subfamily of GPCRs is adhesion GPCRs. The name ‘‘adhe-
sion’’ relates to the N-termini, which contain adhesion-like motifs
such as EGF-like repeats, cadherin domains, or leucine-rich repeats
that are likely to participate in cell–cell adhesion [1–4]. Although
adhesion GPCRs share the same seven-transmembrane topology
with other GPCRs [1–4], there are large variations among their long
extracellular N-termini. In humans, adhesion GPCRs are expressed
in a variety of tissues including the immune system, central ner-
vous system, and endocrine organs, suggesting that they can take
part in a variety of physiological functions. However, the large size
and the genomic complexity of these proteins have made them dif-
ﬁcult to study.
Signaling associated with most GPCRs has been well studied
and usually involves coupling to heterotrimeric G-proteins in the
cell. The activated GTP-bound a-subunit dissociates from the
receptor and activates speciﬁc effectors such as adenylate cyclase
and phospholipases. A majority of GPCRs couple to three types of
Ga-proteins: Gas, Gai/ao and Gaq. Gas and Gai/ao stimulate or inhibit
adenylate cyclase activity, respectively, whereas Gaq activateschemical Societies. Published by Ephospholipase C (PLC) [5]. However, the majority of adhesion
GPCRs are orphans, and their coupling mechanisms are unknown.
Although, CD97, one of the most studied receptors in this family,
has been shown to interact with CD55 [6,7], and a glycosaminogly-
can (chondroitin sulfate) has been shown recently to be a ligand for
EMR2 [8], no G-protein-mediated signaling events (such as calcium
mobilization or inositol phosphate production) have been reported
for those two receptors. Latrophilin was able to induce intracellular
calcium signaling upon binding to a-latrotoxin, but very few re-
ports have shown any G-protein coupled signaling for any other
receptors in this subfamily [9]. Adhesion GPCRs belong to a rela-
tively new GPCR subfamily about which there is limited functional
information. Identifying their signaling pathways and ligands will
provide a path toward understanding their physiological functions.
In this study, we measured the constitutive activities of our in-
house collection of adhesion GPCRs and performed ligand hunting
for one of the receptors as a proof-of-concept study. Several recep-
tors displayed constitutive activity in our in vitro assays. Our re-
sults provide compelling evidence that this subfamily of GPCRs
can also signal through classical GPCR signaling pathways.
2. Experimental procedures
2.1. Materials
[35S] guanosine 50-[c-thio]triphosphate (GTPcS; 1250 Ci/mmol)
was purchased from Perkin–Elmer Life and Analytical Sciences
(Waltham, MA). Unlabeled GTPcS was obtained from Roche
Molecular Biochemicals (Indianapolis, IN). GDP was purchased
from Sigma (St. Louis, MO). PTX was obtained from Calbiochem.
Beclomethasone dipropionate was obtained from Prestwicklsevier B.V. All rights reserved.
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soluble in dimethyl sulfoxide (DMSO) and was stable as a 10 mM
stock. The 10 mM stock solution was then subsequently diluted
into media or buffer to ﬁnal concentrations as indicated in the ﬁg-
ures. The ﬁnal DMSO concentration in the media of all cell-based
assays was 0.1% (v/v) and in GTPcS binding assay was 1% (v/v).
The same ﬁnal DMSO concentrations were also maintained in no
compound control cells or reactions that were set up to eliminate
any potential solvent effects. No precipitation of compounds were
observed either in media or in reaction buffers under the condi-
tions described here.
2.2. Methods
2.2.1. Cloning and cell culture
Full length adhesion GPCRs were cloned into the mammalian
expression vector pcDNA3.1 (Invitrogen). Chinese hamster ovary
(CHO) cells were maintained in Dulbecco’s modiﬁed Eagle’s med-
ium/nutrient mixture F-12 (Cellgro) containing 10% fetal bovine
serum and antibiotics. HEK293 cells were grown in Dulbecco’s
modiﬁed Eagle’s medium containing 10% fetal bovine serum and
antibiotics. All cell lines were cultured at 37 C with 5% CO2. Cells
were transfected with expression vectors using Lipofectamine
2000 (Invitrogen) according to the manufacturer’s protocol.
2.2.2. Inositol phosphate accumulation assay
HEK293 cells seeded in 96-well plates were transfected with
adhesion GPCRs (100 ng/well) and small chimeric G-proteins
(Gqi5, Gqi9, Gqo3, Gqo5, Ga15, Ga16 or Gmyri5 20 ng/well). After label-
ing with [3H]myoinositol (Amersham Biosciences) for 16 h, cells
were treated with Hanks’ buffered salt solution, 25 mM Hepes
(pH 7.4), 10 mM LiCl, 0.01% bovine serum albumin at 37 C for
2 h. Cells were lysed using 20 mM formic acid at 4 C for 4 h.
Ysi-SPA beads (Amersham Biosciences) were added to the cell
lysates and incubated overnight in the dark. Radioactivity was
measured on a Topcount 96/384 scintillation counter (Packard).
2.2.3. cAMP assay
Control HEK 293 cells and HEK 293 cells transiently transfected
with 100 ng/well adhesion GPCRs were transferred to 96-well
plates (approx 1.0–1.5  104 cells per well). Cells were then incu-
bated with 1 mM 3-isobutyl-1-methylxanthine for 30 min at
37 C. Reactions were terminated, and stimulation of adenylyl cy-
clase was measured using the Tropix cAMP Screen system (Applied
Biosystems). For siRNA experiments, cells were co-transfected with
100 ng/well GPCR construct and 1 pmol/well Gas siRNA (sc-29328,
Santa Cruz) or control siRNA (sc-37007, Santa Cruz).
2.2.4. Aequorin assay
For each 10-cm CHO cells dish, 5 lg of GPR97, 5 lg of aequorin
reporter plasmids and 2 lg of G-proteins were used using for tran-
sient transfection. Twenty-four hours after transfection, cells were
harvested and resuspended in Hanks’ buffered salt solution con-
taining 0.01% bovine serum albumin and 20 mM HEPES (Cellgro),
loaded with 1 lg/ml coelenterazine (P. J. K. Industrievertetungen,
Handel, Germany) at room temperature for 1 h, and stimulated
with various compounds. Ligand-induced calcium mobilization,
as indicated by an increase in aequorin luminescence, was re-
corded over a period of 20 s with a Microlumat luminometer
(Berthold).
2.2.5. Flow cytometry analysis
Transiently transfected CHO cells were stained with anti-FLAG
M2 monoclonal antibody in staining buffer (FBS) (BD Pharmigen)
for 1 h at 4 C. After extensive washing, cells were incubated with
goat F(ab’)2 anti-mouse IgG-APC secondary antibody (Caltag) for30 min. Flow cytometry analysis was carried out using FACSCalibur
(BD Biosciences).
2.2.6. Transient transfection and membrane preparation
For each 15-cm cells dish, 10 lg of Goa and 10 lg of Gob expres-
sion constructs were used for transfection into HEK293-GPR97 sta-
ble cells or parental HEK293 cells. Membranes were harvested 48 h
after transfection. Pertussis toxin (100 ng/ml) was added 16 h be-
fore harvesting. All the membrane preparation steps were per-
formed at 4 C. In brief, cells were harvested by centrifugation
(10 min at 10,000g), washed once with phosphate-buffered sal-
ine, resuspended in lysis buffer (10 mM Tris–HCl, pH 7.4, with
1 mM EDTA and protease inhibitors) and lysed using 25 strokes
of a Dounce homogenizer. Nuclei and unbroken cells were re-
moved by centrifugation (5 min at 500g). The supernatant was
centrifuged again (30 min at 40,000g) and the resulting pellet
was washed once with 20 ml of lysis buffer (10 mM Tris–HCl, pH
7.4, alone). Membranes were resuspended at 1.5–2.0 mg/ml pro-
tein in binding buffer (20 mM HEPES pH 7.5, 5 mM MgCl2) and
stored at 80 C until use.
2.2.7. [35S]GTPcS binding
The optimal experimental conditions for the concentrations of
GDP, MgCl2, and NaCl in the assay buffer were initially determined.
The assay was performed in assay buffer [20 mM HEPES, pH 7.5,
5 mM MgCl2, and 0.1% (w/v) BSA] with 100 mM NaCl, 1 lM GDP,
and 20 lg of membranes/well. No NaCl was included for determin-
ing constitutive activity of the receptor. The reaction was initiated
by addition of 0.4 nM [35S]GTPcS in the absence or presence of
beclomethasone dipropionate and incubated at room temperature
for 90 min. Non-speciﬁc binding was determined in the presence of
100 lM GTPcS and was always less than 0.2% of total binding.
Bound [35S]GTPcS was separated from free [35S]GTPcS by ﬁltration
through GF/B ﬁlters followed by ﬁve washes with 200 ll of ice-cold
assay buffer. Filter-bound radioactivity was determined by liquid
scintillation counting.
3. Results
Knowledge of downstream signaling can be gained by evaluat-
ing whether an orphan receptor is constitutively active. Gas- and
Gaq-coupled receptors can be evaluated for constitutive activity
via the measurement of cAMP or inositol phosphate accumulation
in cells transfected with high levels of receptor expression vectors.
For Gai- or Gao-coupled receptors, chimeric G-proteins can be used
to convert signals to Gaq – mediated signaling pathways. Chimeric
G-proteins are created by replacing the C-terminal amino acids of
Gaq with the corresponding amino acids from Gai- or Gao-proteins
(Fig. 1A). This allows measurement of receptor activity using an
inositol phosphate accumulation assay, which is generally more
robust than traditional adenylate cyclase assays [10].
We transfected our collections of adhesion GPCRs (listed in Ta-
ble 1) together with each individual chimeric G-proteins into
HEK293 cells and performed inositiol phosphate accumulation as-
says. Ga15 and Ga16 were also included since they have been shown
to couple to a variety of Gas, Gai/ao and Gaq dependent receptors.
Four receptors showed constitutive activities (Fig. 1B). Among
them, GPR115 and EMR2 are active when cotransfected with
Ga15. GPR110 is constitutively active even in the absence of any
G-proteins, suggesting that it couples to endogenous Gaq-protein.
GPR97 requires chimeric protein Gqo3 to induce inositol phosphate
accumulation, indicating it primarily couples to Gao-protein. We
also transfected adhesion GPCRs into HEK293 cells and measured
the cAMP accumulation after 24 h. Among them, GPR114 and
GPR133-transfected cells showed high levels of cAMP compared
with the transfection control and other receptors (Fig. 2A), suggest-
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Fig. 1. Constitutive activity in the inositol phosphate accumulation assay. (A) Schematic depiction of the chimeric G-proteins used in this study. (B) HEK293 cells were
transiently transfected with GPCR plasmid alone or co-transfected with various chimeric G-proteins. Control vector containing aequorin cDNA served as a negative control.
Twenty-four hours after transfection, the cells were incubated with HBSS containing 10 mM LiCl for 1 h. Total inositol phosphates were determined and results presented as
the mean of quadruplicate determinations. The results have also been conﬁrmed by multiple independent experiments.
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Gas-proteins are directly involved in GPR114 and GPR133 signal-
ing, we used siRNA to speciﬁcally knock down the endogenous
Gas-proteins. Co-transfection of siRNA and GPR114 or GPR133
abolished the increases in cAMP levels, while control siRNA has
no effect (Fig. 2B), clearly demonstrating GPR114 and GPR133
can signal through Gas coupling. GPR133 coupling to Gas-proteins
has also been conﬁrmed recently in an independent study [11].
GPR97 belongs to an interesting cluster of adhesion GPCRs en-
riched in immune cells [12]. To test whether adhesion GPCRs can
also activate intracellular signaling upon small molecule ligand
binding, we started a proof-of-concept study using GPR97 and
screened the Prestwick Chemical Library (Prestwick Chemical,France) for activators of Ca2+ mobilization using an aequorin assay.
CHO cells were transiently transfected with GPR97, aequorin re-
porter, and Gqo3, which will convert the Gao-coupled signaling to
Ca2+ signaling. Beclomethasone dipropionate evoked a speciﬁc rise
in [Ca2+]i in cells expressing human GPR97 and Gqo3, with a median
effective concentration (EC50) of 46 nM (Fig. 3). No speciﬁc re-
sponse was observed in control cells not co-transfected with either
GPR97 or Gqo3 (Fig. 3). Beclomethasone dipropionate (structure
shown in Fig. 3) is a potent glucocorticoid steroid from Prestwick
Chemical Library. But the fact that beclomethasone dipropionate
only activates cells when both GPR97 and Gqo3 were expressed
and the acuteness of the response time suggest the signals from
the aequorin assay are unlikely due to the activation of the
Table 1
List of adhesion GPCRs tested in this study.
GPCR Species
CD97 Human
EMR2 Human
ETL1 Human
BAI1 Human
BAI2 Mouse
BAI3 Human
CELSR3 Human
GPR97 Human
GPR110 Mouse
GPR114 Human
GPR115 Mouse
GPR116 Human
GPR123 Mouse
GPR124 Human
GPR125 Human
GPR126 Human
GPR133 Human
GPR56 Human
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Fig. 2. Constitutive activity in cAMP accumulation assay. (A) HEK293 cells were
transiently transfected with adhesion GPCR plasmid, and aequorin cDNA was used
as vector control. After 24 h, cells were incubated with 1 mM 3-isobutyl-1-
methylxanthine for 30 min at 37 C. Reactions were terminated and concentration
of adenylyl cyclase was measured. Results are presented as the mean of quadru-
plicate determinations. The results have also been conﬁrmed by multiple indepen-
dent experiments. (B) HEK293 cells were co-transfected with GPR114, GPR133 or
vector control together with Gas siRNA or control siRNA. After 48 h, cells were
incubated with 1 mM 3-isobutyl-1-methylxanthine for 30 min at 37 C. Reactions
were terminated and concentration of adenylyl cyclase was measured.
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library in the future should let us identify more speciﬁc com-
pounds for GPR97 without other cellular targets.
To ensure that the observed activity was mediated by cell sur-
face expressed GPR97, N-terminal FLAG-tagged GPR97 was gener-
ated to study the cellular localization of GPR97. FLAG-GPR97
behaved similarly to wild-type GPR97 in both the inositiol phos-
phate accumulation assay and the aequorin assay (data not
shown). Flow cytometry analysis conﬁrmed cell surface expression
of GPR97 on CHO cells transfected with FLAG tagged GPR97, and
co-transfection of chimeric G-protein Gqo3 had no effect on its sur-
face expression (Fig. 4).
To further conﬁrm that GPR97 indeed couples through Go-pro-
teins upon activation, we performed an [35S]GTPcS incorporation
assay using membrane preparations from HEK293–GPR97 stable
cells transiently transfected with Goa and Gob G-proteins, and
parental HEK293 cells transfected with Goa and Gob were used as
a negative control. Membranes from HEK293–GPR97 stable cells
showed constitutive activity of about 10% over control cells
(P < 0.0128, unpaired T-test, two tailed) (Fig. 5A). Similar to the re-
sults from the aequorin assay, we also found that beclomethasone
dipropionate stimulated G-protein coupling to the GPR97 receptor
in a concentration-dependent manner (Fig. 5B). The EC50 for beclo-
methasone dipropionate-induced activation of human GPR97 in
[35S]GTPcS binding assay was 3.1 nM. The discrepancy of the EC50
numbers between the aequorin assay and the [35S]GTPcS binding
assay could be due to the different receptor coupling efﬁciency be-
tween chimeric G-protein Gqo3 and Goab G-proteins. This agonist-
induced effect was abolished upon treatment with pertussis toxin
(PTX), indicating that GPR97 couples to PTX-sensitive Gi/Go G-pro-
teins (data not shown). No signiﬁcant response was obtained using
membranes from parental HEK293 cells transfected with Goa and
Gob G-proteins (Fig. 5B). Our results provided strong evidence that
GPR97 can be activated by a small molecule compound, beclometh-
asone dipropionate, through coupling to Go protein.4. Discussion
G-protein-coupled receptors (GPCRs) share a common molecu-
lar architecture comprising a seven-transmembrane domain. They
also share a common signaling mechanism of interacting with G-
proteins (heterotrimeric GTPases) in regulating intracellular sec-
ondary messengers such as cyclic AMP, inositol phosphates, and
calcium ions [5]. Adhesion GPCRs belong to a large subfamily of
GPCRs whose members are potentially involved in a variety of
physiological activities [1]. However, functional data for the major-
ity of adhesion GPCRs are very limited due to the lack of proper
tool compounds to probe their functions. We tested a large number
of our in-house collection of adhesion GPCRs to understand their
signaling mechanisms and found several to be constitutively active
and capable of coupling to different G-proteins. Such information
could shed light on the possible physiological roles played by those
receptors. For example, the fact that GPR133 is enriched on beta
cell surface with constitutive Gas-protein coupling activity to acti-
vate cAMP production raises the interesting possibility for its
involvement in insulin secretion. EMR2, GPR114 and GPR97 are
all expressed in the immune cells, so it is reasonable to speculate
that their signaling activities might contribute to immune re-
sponses such as cytokine release and cell migration, as demon-
strated by many canonical GPCRs enriched in the immune
system. Other separate studies from recent literature also support
our ﬁnding that adhesion GPCRs can signal through classical G-
protein-coupled pathway [11,13]. The actual number of the recep-
tors having constitutive activities might be even higher since we
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Fig. 3. Identiﬁcation of beclomethasone dipropionate as a ligand for GPR97. Dose-dependent activation of human GPR97 by beclomethasone dipropionate. CHO cells were
transfected with an aequorin expression vector and human GPR97 or a vector control in the presence or absence of plasmids expressing the chimeric G-protein, Gqo3. Ligand-
induced [Ca2+] increase was recorded as the aequorin luminescence signal for 20 s after the compounds were added and data were plotted as fold change over vehicle treated
cells. The results presented as the mean of duplicated determinations and have been conﬁrmed by multiple independent experiments. The structure of beclomethasone
dipropionate is shown on the right.
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with vector control, ﬂag-GPR97, or ﬂag-GPR97 + Gqo3. After 48 hours, cells were
harvested and incubated with anti-FLAG antibody and goat F(ab’)2 anti-mouse IgG-
allophycocyanin (APC) secondary antibody before ﬂow cytometry analysis.
-10.5 -9.5 -8.5 -7.5 -6.5 -5.5 -4.5
94
102
110
118
126
Stable cell line
Parental cells
Beclomethasone dipropionate  (Log M)
[3
5S
]G
TP
γS
bi
nd
in
g
(%
 o
ve
r b
as
al
)
[3
5 S
]G
TP
γS
 b
in
di
ng
(%
 o
ve
r b
as
al
)
pa
ren
tal
  c
ell
s
Sta
ble
 ce
ll l
ine
90
95
100
105
110
115
120
P<0.0128
*
A
B
Fig. 5. [35S]GTPcS incorporation assay. (A) Constitutive activity of GPR97 in GTPcS
binding assay (black bar) and control (white bar). Data are the mean of two
independent experiments. Control activity (considered 100%) is from parental
HEK293 cells co-transfected with Goa and Gob-proteins. (B) Concentration-depen-
dent increase of GTPcS binding by beclomethasone dipropionate from HEK293–
GPR97 stable cell membranes. GTPcS binding assay was carried out as described in
the Section 2. Basal (100%) represents response in the absence of any ligand. Data
shown are the mean ± S.E.M of three to four independent experiments performed in
duplicates or triplicates. Data were analyzed by non-linear regression and were best
ﬁtted to agonist dose–response curves.
1218 J. Gupte et al. / FEBS Letters 586 (2012) 1214–1219could have missed the receptors that have poor expression levels
under our assay conditions.
Furthermore, through screening a small-molecule library, we
identiﬁed a compound that will activate GPR97 in the presence
of the corresponding G-protein. This is the ﬁrst time that a small
chemical compound has been shown to activate a member of the
adhesion GPCR subfamily. Our study generated convincing evi-
dence that adhesion GPCRs can signal through G-proteins and acti-
vate intracellular secondary messenger production similar to other
well-studied classic GPCRs. Using a conventional screening plat-
form, we could potentially identify their agonists and use them
as tools for probing the physiological functions of these receptors.
For example, GPR97 has been implicated in being involved in earlylymphoid development since it is speciﬁcally expressed in pre-B
cells and thymocytes but not in mature B and T cells. However,
J. Gupte et al. / FEBS Letters 586 (2012) 1214–1219 1219GPR97-deﬁcient mice did not display any signiﬁcant quantitative
or qualitative defects in B- and T-cell development [14]. But that
does not exclude a role for GPR97 in B- and T- cell development,
as there might be proteins which are functionally redundant carry-
ing out its function, suggesting that loss of function approaches
such as gene knockout alone may not be sufﬁcient to elucidate
the function of a gene. In this case, having a speciﬁc agonist for
GPR97 that stimulates the signaling activity can be very useful
for the functional study.
The unique property of the adhesion family GPCRs is their long
N-termini, which contain multiple domains that may be involved
in cell–cell adhesion [1]. A great deal of research has focused on
their interactions with other cell surface molecules. For example,
CD97 has been shown to interact with the cell surface protein
CD55 since CD97-expressing cells are able to adhere to CD55 posi-
tive erythrocytes [6,7]. It is not clear whether the adhesion func-
tion of this class of GPCRs is independent or related to the
intracellular signaling activities. A recent study showed puriﬁed
cadherin repeats of Celsr2 or Celsr3 can increase the intracellular
calcium level in cells expressing those two receptors [15]. Whether
this is receptor speciﬁc or common among the subfamily requires
further investigation.
In summary, we utilized an over-expression system and candi-
date approach, which have been successfully applied to deorphan-
ize and characterize many canonical GPCRs, to generate convincing
evidence for the signaling activities from this subfamily of GPCRs.
We believe this strategy is the best option at the current stage to
guide the efforts for tool compound generation. Once proper li-
gands are identiﬁed, studies can be carried out under more physi-
ologically relevant settings to validate the signaling results and
other molecular biology tools such as siRNA can be used in loss
of function studies for further understandings of the biological
functions of these receptors.Acknowledgements
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